Security
Matinas BioPharma Holdings, Inc. · MTNB
MTNBNYSE_AMERICANCommon stockCurrentCIK 1582554Updated Oct 6, 2026
MTNB price & chart
Loading TradingView…
AMEX:MTNB on TradingView ↗In the news
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance ↗
Recent filings
Other Events
Items 8.01
Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Items 3.03, 5.03, 9.01
Other Events
Items 8.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Other Events
Items 3.01, 8.01, 9.01
425 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 9,695,000Source | 20,577,000Source | 3,412,000Source | 11,424,000Source | 24,365,000Source | 5,874,000Source | 12,035,000Source | 19,610,000Source | 7,208,000Source | 12,641,000Source | 25,104,000Source | 44,819,000Source |
| Property, Plant and Equipment, NetUSD | 156,000Source | 1,648,000Source | — | 158,000Source | 1,739,000Source | 138,000Source | 450,000Source | 1,829,000Source | 138,000Source | 468,000Source | 1,923,000Source | 2,091,000Source |
| GoodwillUSD | — | 1,336,000Source | — | — | 1,336,000Source | — | — | 1,336,000Source | — | — | 1,336,000Source | 1,336,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 2,260,000Source | 3,017,000Source | 2,260,000Source | 2,260,000Source | 3,017,000Source | 2,260,000Source | 2,260,000Source | 3,017,000Source | 2,260,000Source | 2,260,000Source | 3,017,000Source | 3,017,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 5,435,000Source | 10,295,000Source | 761,000Source | 6,525,000Source | 4,216,000Source | 2,398,000Source | 6,924,000Source | 1,071,000Source | 3,999,000Source | 7,284,000Source | 4,787,000Source | 6,830,000Source |
| Assets, CurrentUSD | 5,653,000Source | 11,741,000Source | 1,143,000Source | 7,268,000Source | 15,285,000Source | 2,815,000Source | 7,547,000Source | 10,289,000Source | 4,075,000Source | 8,025,000Source | 15,543,000Source | 34,532,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 168,000Source | 896,000Source | 332,000Source | 693,000Source | 922,000Source | 367,000Source | 573,000Source | 2,129,000Source | 26,000Source | 691,000Source | 1,737,000Source | 5,719,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,351,000Source | 2,618,000Source | 6,000Source | 1,462,000Source | 2,770,000Source | 457,000Source | 1,571,000Source | 2,919,000Source | 531,000Source | 1,680,000Source | 3,064,000Source | 3,613,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 3,235,000Source | 4,798,000Source | 1,612,000Source | 3,749,000Source | 5,262,000Source | 2,852,000Source | 5,765,000Source | 5,052,000Source | 2,378,000Source | 5,051,000Source | 5,858,000Source | 8,182,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 1,000Source | 1,000Source | 1,000Source | 1,000Source | 25,000Source | 1,000Source | 1,000Source | 22,000Source | 1,000Source | 1,000Source | 22,000Source | 22,000Source |
| Additional Paid in CapitalUSD | — | 207,169,000Source | — | 214,399,000Source | 206,245,000Source | — | 207,749,000Source | 196,067,000Source | — | 207,413,000Source | 195,018,000Source | 190,070,000Source |
| Retained Earnings (Accumulated Deficit)USD | -208,875,000Source | -191,391,000Source | -214,034,000Source | -206,725,000Source | -187,116,000Source | -212,708,000Source | -201,480,000Source | -181,397,000Source | -210,787,000Source | -199,824,000Source | -175,573,000Source | -152,631,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | — | — | — | -51,000Source | — | — | -134,000Source | — | — | -221,000Source | -824,000Source |
| Stockholders' Equity Attributable to ParentUSD | 6,460,000Source | 15,779,000Source | 1,800,000Source | 7,675,000Source | 19,103,000Source | 3,022,000Source | 6,270,000Source | 14,558,000Source | 4,830,000Source | 7,590,000Source | 19,246,000Source | 36,637,000Source |
| Additional Paid in Capital, Common StockUSD | 215,334,000Source | — | 215,833,000Source | — | — | 215,729,000Source | — | — | 215,616,000Source | — | — | — |
| Liabilities and EquityUSD | 9,695,000Source | 20,577,000Source | 3,412,000Source | 11,424,000Source | 24,365,000Source | 5,874,000Source | 12,035,000Source | 19,610,000Source | 7,208,000Source | 12,641,000Source | 25,104,000Source | 44,819,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 1,495,000Source | 2,124,000Source | 1,350,000Source | 1,784,000Source | 2,392,000Source | 2,126,000Source | 2,255,000Source | 1,998,000Source | 1,463,000Source | 2,666,000Source | 2,622,000Source | 4,286,000Source |
| Operating Lease, Liability, CurrentUSD | 846,000Source | 733,000Source | — | 817,000Source | 707,000Source | 718,000Source | 788,000Source | 681,000Source | 694,000Source | 761,000Source | 656,000Source | 562,000Source |
| Accounts Payable, CurrentUSD | 80,000Source | 349,000Source | 845,000Source | 167,000Source | 238,000Source | 712,000Source | 282,000Source | 473,000Source | 315,000Source | 95,000Source | 514,000Source | 618,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,472,000Source | 2,319,000Source | — | 1,697,000Source | 2,514,000Source | 464,000Source | 1,909,000Source | 2,697,000Source | 653,000Source | 2,116,000Source | 2,877,000Source | 3,533,000Source |
| Deferred Income Tax Liabilities, NetUSD | 257,000Source | 341,000Source | 257,000Source | 257,000Source | 341,000Source | 257,000Source | 257,000Source | 341,000Source | 257,000Source | 257,000Source | 341,000Source | 341,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 564,000Source | 1,037,000Source | 504,000Source | 795,000Source | 1,442,000Source | 694,000Source | 1,179,000Source | 839,000Source | 452,000Source | 1,801,000Source | 1,447,000Source | 3,099,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 0Source | 18,000Source | 32,000Source | 365,000Source | 385,000Source | 337,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 253,000Source | 965,000Source | 104,000Source | 238,000Source | 113,000Source | 315,000Source | 1,023,000Source | 3,195,000Source | 4,948,000Source | 5,228,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 397,000Source | 187,000Source | 220,000Source | -419,000Source | -103,000Source | -321,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | -84,000Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -1,601,000Source | -2,007,000Source | -7,011,000Source | -15,885,000Source | -15,278,000Source | -19,156,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | — | 335,000Source | 9,208,000Source | 13,242,000Source | 4,877,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | — | — | 218,000Source | 892,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | — | 1,647,000Source | 3,391,000Source | 9,174,000Source | -7,000Source | 79,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -1,601,000Source | -360,000Source | -3,285,000Source | 2,497,000Source | -2,043,000Source | -14,200,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | — | — | — | — | — | 7,080,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 7,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| DepreciationUSD | — | — | — | — | — | — | — | — | 2,064,000Source | — | 59,000Source | 5,000Source |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | — | — | — | — | — | 37,000Source | — | — | — |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | 484,000Source | 3,491,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | -138,000Source | 110,000Source | — | — | 55,000Source | — | -1,000Source | -2,000Source |
| Gain (Loss) on Disposition of Assets for Financial Service OperationsUSD | — | — | — | — | — | — | — | — | 37,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 1,577,000Source | 2,142,000Source | 1,555,000Source | 1,837,000Source | 1,936,000Source | 1,861,000Source | 6,875,000Source | 8,729,000Source | 10,373,000Source | 11,100,000Source |
| GoodwillUSD | — | — | — | 1,336,000Source | — | — | — | — | — | — | 1,336,000Source | 1,336,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | 1,336,000Source | — | 0Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | — | — | — | — | — | — | — | 2,338,000Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | -80,000Source | — | — |
| Marketable Securities, Unrealized Gain (Loss)USD | — | — | — | — | — | — | — | — | — | — | — | 679,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,532,000Source | -4,275,000Source | -1,326,000Source | -5,245,000Source | -1,921,000Source | -1,656,000Source | -10,345,000Source | -24,251,000Source | -22,942,000Source | -20,997,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -2,150,000Source | -4,275,000Source | -1,326,000Source | -5,245,000Source | -1,921,000Source | -1,656,000Source | -10,963,000Source | — | — | -20,997,000Source |
| Operating Lease, Impairment LossUSD | — | — | — | — | — | — | — | — | — | 1,090,000Source | — | — |
| Other Nonoperating Income (Expense)USD | — | — | 45,000Source | 106,000Source | -1,000Source | -63,000Source | 15,000Source | -4,000Source | -261,000Source | 262,000Source | 340,000Source | 102,000Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | — | 2,000Source | 29,000Source | — | — | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | — | — | 99,000Source |
| Gain (Loss) on Termination of Lease | — | — | — | — | —Source | — | — | — | — | — | — | — |
| Proceeds from Issuance of Common Stock | — | — | — | — | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | — | — | — | — | — | — | — | — | 1,096,000Source | 3,188,000Source |
| Operating Income (Loss)USD | — | — | -1,577,000Source | -4,381,000Source | -1,555,000Source | -1,837,000Source | -1,936,000Source | -1,946,000Source | -6,960,000Source | -24,593,000Source | -23,766,000Source | -24,590,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 45,000Source | 106,000Source | -1,000Source | -63,000Source | 15,000Source | -4,000Source | -261,000Source | 262,000Source | 340,000Source | 102,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | -10,345,000Source | -24,331,000Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | -80,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,532,000Source | -4,275,000Source | -1,326,000Source | -5,245,000Source | -1,921,000Source | -1,656,000Source | -10,345,000Source | -24,251,000Source | -22,942,000Source | -20,997,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.4Source | -0.85Source | -0.21Source | -1.03Source | -0.3Source | -0.33Source | -2Source | -4.98Source | -0.11Source | -0.1Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.4Source | -0.85Source | -0.21Source | -1.03Source | -0.3Source | -0.33Source | -2Source | -4.98Source | -0.11Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 5,435,829Source | 5,037,829Source | 6,406,191Source | 5,086,985Source | 6,406,191Source | 5,086,985Source | 5,474,129Source | 4,865,829Source | 217,264,526Source | 216,811,439Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 5,435,829Source | 5,037,829Source | 6,406,191Source | 5,086,985Source | 6,406,191Source | 5,086,985Source | 5,474,129Source | 4,865,829Source | 217,264,526Source | — |
| Additional Financial Items | ||||||||||||
| Costs and ExpensesUSD | — | — | 1,577,000Source | 4,381,000Source | 1,555,000Source | 1,837,000Source | 1,936,000Source | 1,946,000Source | 6,960,000Source | 24,593,000Source | 24,862,000Source | 27,778,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 7,000Source | 4,000Source | — | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 2,000Source | 90,000Source | — | — | 0Source | 18,000Source | 32,000Source | 365,000Source | 385,000Source | 337,000Source |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | 484,000Source | 3,491,000Source |
| General and Administrative ExpenseUSD | — | — | 1,577,000Source | 2,142,000Source | 1,555,000Source | 1,837,000Source | 1,936,000Source | 1,861,000Source | 6,875,000Source | 8,729,000Source | 10,373,000Source | 11,100,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | 1,336,000Source | — | 0Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -2,150,000Source | -4,275,000Source | -1,326,000Source | -5,245,000Source | -1,921,000Source | -1,656,000Source | -10,963,000Source | — | — | -20,997,000Source |
| Other General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Research and Development ExpenseUSD | — | — | — | 2,239,000Source | — | — | — | 85,000Source | 85,000Source | 11,433,000Source | 14,489,000Source | 16,678,000Source |
| Preferred Stock Dividends, Income Statement Impact | — | — | —Source | — | — | — | — | — | — | — | — | — |
Offerings
Registration 333-296813
Filing attachments
ex99-1.htm · 8-K · 2026-09-04
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards BEDMINSTER, N.J. (September 4, 2026) - Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on August 31, 2026, it received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section…
Read attachment ↗ex4-1.htm · 425 · 2026-07-13
Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSA…
Read attachment ↗ex4-2.htm · 425 · 2026-07-13
Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSA…
Read attachment ↗ex4-3.htm · 425 · 2026-07-13
Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSA…
Read attachment ↗ex99-1.htm · 425 · 2026-07-13
Exhibit 99.1 Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals Will create publicly traded advanced clean energy company focused on modular carbon-free energy, green hydrogen, critical materials and industrial decarbonization Business Combination expected to provide public ma…
Read attachment ↗ex4-1.htm · 8-K · 2026-07-13
EX-4.1 5 ex4-1.htm EX-4.1 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE …
Read attachment ↗